| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution. Further expanding its pharmaceutical offerings, Baxter delivers pre-mixed and oncology drug platforms, inhaled anesthetic …
Over the last 12 months, insiders at Baxter International Inc. have bought $0 and sold $0 worth of Baxter International Inc. stock.
On average, over the past 5 years, insiders at Baxter International Inc. have bought $0 and sold $3.65M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 19,560 shares for transaction amount of $1.61M was made by Martin Sean (SVP and General Counsel) on 2020‑03‑30.
| 2024-03-01 | Sale | Mason Jeanne K | EVP, Chief HR Officer | 64,488 0.0126% | $40.61 | $2.62M | -12.73% | |
| 2023-02-21 | Sale | Kunzler Jacqueline | SVP, Chief Quality Officer | 3,813 0.0008% | $40.50 | $154,427 | -0.35% | |
| 2023-01-17 | Sale | Mason Jeanne K | SVP, Human Resources | 59,477 0.0118% | $44.70 | $2.66M | -8.36% | |
| 2022-04-05 | Sale | STROUCKEN ALBERT P L | 1,215 0.0002% | $76.63 | $93,105 | -26.34% | ||
| 2022-04-05 | Sale | HELLMAN PETER S | 2,827 0.0006% | $75.76 | $214,174 | -26.34% | ||
| 2022-04-01 | Sale | FORSYTH JOHN D | 1,005 0.0002% | $77.68 | $78,068 | -27.91% | ||
| 2022-03-01 | Sale | FORSYTH JOHN D | director | 1,005 0.0002% | $84.82 | $85,244 | -30.01% | |
| 2022-02-28 | Sale | Stevens Brian | SVP, CAO and Controller | 2,500 0.0005% | $85.50 | $213,757 | -30.68% | |
| 2022-02-14 | Sale | Mason Jeanne K | SVP, Human Resources | 54,143 0.0107% | $85.02 | $4.6M | -29.87% | |
| 2022-02-02 | Sale | Chen Thomas F | director | 1,680 0.0003% | $84.53 | $142,010 | -28.82% | |
| 2022-02-01 | Sale | FORSYTH JOHN D | director | 1,005 0.0002% | $85.59 | $86,018 | -27.60% | |
| 2021-11-01 | Sale | Martin Sean | SVP and General Counsel | 21,450 0.0043% | $79.57 | $1.71M | -6.90% | |
| 2021-08-02 | Sale | Martin Sean | SVP and General Counsel | 19,800 0.004% | $77.26 | $1.53M | +2.65% | |
| 2021-04-12 | Sale | Frye Andrew | SVP, President, APAC | 21,998 0.0044% | $84.79 | $1.87M | -3.29% | |
| 2021-04-05 | Sale | STROUCKEN ALBERT P L | director | 9,980 0.0013% | $57.91 | $577,942 | -3.92% | |
| 2021-04-05 | Sale | HELLMAN PETER S | director | 9,980 0.002% | $84.56 | $843,909 | -3.92% | |
| 2020-11-02 | Sale | Martin Sean | SVP and General Counsel | 94,002 0.0184% | $78.67 | $7.4M | +3.35% | |
| 2020-09-14 | Sale | FORSYTH JOHN D | director | 620 <0.0001% | $57.42 | $35,604 | -3.00% | |
| 2020-09-03 | Sale | Kunzler Jacqueline | SVP, Chief Quality Officer | 5,314 0.0011% | $85.87 | $456,313 | -3.32% | |
| 2020-08-03 | Sale | GAVIN JAMES R III | director | 29,798 0.0061% | $86.41 | $2.57M | -1.96% |
| Baxter Healthcare SA | 10 percent owner | 2603295 0.5032% | $66.36M | 1 | 0 | <0.0001% |
| KRAEMER HARRY M JANSEN JR | Chairman and | 694556 0.1343% | $17.7M | 1 | 0 | +11.7% |
| PARKINSON ROBERT L JR | Chairman of the Board & CEO | 465485 0.09% | $11.87M | 2 | 6 | +5.4% |
| JEHARAJAH NEVILLE J | Corporate Vice President | 127603 0.0247% | $3.25M | 1 | 0 | +8.11% |
| GREISCH JOHN J | Corporate Vice President | 90419 0.0175% | $2.3M | 2 | 2 | +1.85% |
| Martin Sean | SVP and General Counsel | 42281 0.0082% | $1.08M | 1 | 3 | <0.0001% |
| STROUCKEN ALBERT P L | 34127 0.0066% | $869,897.23 | 6 | 9 | +7.76% | |
| HELLMAN PETER S | 28822 0.0056% | $734,672.78 | 2 | 8 | +15.49% | |
| Devitt Blake E | director | 16541 0.0032% | $421,630.09 | 2 | 3 | +4.92% |
| ALMEIDA JOSE E | Chairman of the Board and CEO | 11691 0.0023% | $298,003.59 | 1 | 0 | +11.45% |
| Increased Positions | 360 | +41.67% | 84M | +16.2% |
| Decreased Positions | 370 | -42.82% | 51M | -9.89% |
| New Positions | 109 | New | 10M | New |
| Sold Out Positions | 126 | Sold Out | 14M | Sold Out |
| Total Postitions | 854 | -1.16% | 554M | +6.32% |
| Blackrock, Inc. | $1.52M | 15.14% | 77.83M | +10M | +14.91% | 2025-09-30 |
| Vanguard Group Inc | $1.22M | 12.17% | 62.53M | +335,314 | +0.54% | 2025-09-30 |
| Dodge & Cox | $1.12M | 11.17% | 57.4M | +5M | +10.12% | 2025-09-30 |
| Pzena Investment Management Llc | $1.12M | 11.17% | 57.39M | +18M | +45.89% | 2025-09-30 |
| State Street Corp | $428,946.00 | 4.28% | 22M | +60,063 | +0.27% | 2025-09-30 |
| Fmr Llc | $284,152.00 | 2.84% | 14.57M | +11M | +258.14% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $262,320.00 | 2.62% | 13.45M | -9M | -38.75% | 2025-09-30 |
| Geode Capital Management, Llc | $244,478.00 | 2.44% | 12.54M | -345,646 | -2.68% | 2025-09-30 |
| Invesco Ltd. | $169,746.00 | 1.69% | 8.7M | -198,012 | -2.22% | 2025-09-30 |
| Harris Associates L P | $165,213.00 | 1.65% | 8.47M | -875,994 | -9.37% | 2025-09-30 |